↓ Skip to main content

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists

Overview of attention for article published in Cardiovascular Diabetology, October 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
213 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Published in
Cardiovascular Diabetology, October 2014
DOI 10.1186/s12933-014-0142-7
Pubmed ID
Authors

Francisco Kerr Saraiva, Andrei C Sposito

Abstract

Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular disease when compared with nondiabetic controls. Myocardial infarction and stroke are responsible for 75% of all death in patients with diabetes, who present a 2-4x increased incidence of death from coronary artery disease. Patients with diabetes are considered for cardiovascular disease secondary prevention because their risk level is similar to that reported in patients without diabetes who have already suffered a myocardial infarction. More recently, with a better risk factors control, mainly in intensive LDL cholesterol targets with statins, a significant decrease in acute cardiovascular events was observed in population with diabetes. Together with other major risk factors, type 2 diabetes must be considered as an important cause of cardiovascular disease.Glucagon like peptide-1 receptor agonists represent a novel class of anti-hyperglycemic agents that have a cardiac-friendly profile, preserve neuronal cells and inhibit neuronal degeneration, an anti-inflammatory effect in liver protecting it against steatosis, increase insulin sensitivity, promote weight loss, and increase satiety or anorexia.This review is intended to rationally compile the multifactorial cardiovascular effects of glucagon-like peptide-1 receptor agonists available for the treatment of patients with type 2 diabetes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 213 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Russia 1 <1%
Unknown 210 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 46 22%
Student > Ph. D. Student 28 13%
Student > Bachelor 28 13%
Student > Postgraduate 21 10%
Researcher 19 9%
Other 29 14%
Unknown 42 20%
Readers by discipline Count As %
Medicine and Dentistry 89 42%
Agricultural and Biological Sciences 24 11%
Biochemistry, Genetics and Molecular Biology 20 9%
Pharmacology, Toxicology and Pharmaceutical Science 19 9%
Nursing and Health Professions 3 1%
Other 12 6%
Unknown 46 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2023.
All research outputs
#14,028,219
of 24,795,084 outputs
Outputs from Cardiovascular Diabetology
#705
of 1,574 outputs
Outputs of similar age
#121,907
of 266,062 outputs
Outputs of similar age from Cardiovascular Diabetology
#8
of 14 outputs
Altmetric has tracked 24,795,084 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,574 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.